ABOS stock results show that Acumen Pharmaceuticals beat analyst estimates for earnings per share the first quarter of ...
In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Buy rating on Acumen Pharmaceuticals (ABOS – ...
AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in May 2024Initiation of a Phase 1 study to support a subcutaneous dosing option of sabirnetug ...
Samantha Schaeffer; Analyst; Cantor Fitzgerald, L.P.
Acumen Pharmaceuticals has dosed the first patient in ALTITUDE-AD, a Phase II trial designed to evaluate the clinical ...
Real Madrid claimed a record-extending 36th LaLiga title on Saturday after Girona's 4-2 thrashing of local rivals Barcelona ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE – Research Report), ...
The flag bearer of the New Patriotic Party NPP has expressed deep sorrow over the passing of former Member of Parliament for ...
Sixteen high school students from across the province showcased their business acumen and personal finance prowess in the ...
Umesh Pagariya, torchbearer of Pagariya Group, upholds family traditions with visionary innovation in Jalgaon, rooted in ...
Acumen Media launches this month’s edition of the highly anticipated ‘Innovators & Disruptors’ documentary series, going live on CBS News and Acumen Stories. This series showcases pioneering ...